Publication date: November 2026 Source: Biomedicine & Pharmacotherapy, Volume 204 Author(s): Ana Sofia Boasinha, Fernanda Murtinheira, Constança L. Pimenta, Pedro Ferreira-Peralta, Francisco R. Pinto, João Belo, Mário S. Rodrigues, Federico Herrera
Withaferin A induces a decrease in sacsin levels and the collapse of nestin networks: Relevance for glioblastoma. // Biomedicine & Pharmacotherapy. – URL: https://www.sciencedirect.com/science/article/pii/S0753332226010103?dgcid=rss_sd_all
Withaferin A induces a decrease in sacsin levels and the collapse of nestin networks: Relevance for glioblastoma. Biomedicine & Pharmacotherapy. https://www.sciencedirect.com/science/article/pii/S0753332226010103?dgcid=rss_sd_all
“Withaferin A induces a decrease in sacsin levels and the collapse of nestin networks: Relevance for glioblastoma.” Biomedicine & Pharmacotherapy.
@article{article38151,
title = {Withaferin A induces a decrease in sacsin levels and the collapse of nestin networks: Relevance for glioblastoma},
journal = {Biomedicine \& Pharmacotherapy},
url = {https://www.sciencedirect.com/science/article/pii/S0753332226010103?dgcid=rss_sd_all}
}
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01953-z IRAK4 inhibitor DW18134 ameliorates diffuse large B-cell lymphoma in combination with ibrutinib and overcomes acquired resistance to ibrutinib
Acta Pharmacologica Sinica, Published online: 16 November 2026; doi:10.1038/s41401-026-01958-8 Artificial intelligence aids multi-omics data integration in cancer drug discovery and development: from targets to drug synergy
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00179-2 The NIH’s P. J. Brooks discusses the challenges and opportunities ahead for gene therapies and gene editing for diseases of no commercial interest.
Nature Reviews Drug Discovery, Published online: 13 November 2026; doi:10.1038/d41573-026-00181-8 Merck and Moderna’s intismeran autogene succeeded in a landmark melanoma trial, but the oncology community still has more questions than...